Serono technique could boost CJD (Creutzfeldt-Jakob disease) blood test sensitivity
This article was originally published in Clinica
Executive Summary
Researchers at the Serono Pharmaceutical Research Institute in Geneva, Switzerland have developed a technique for amplifying the amount of abnormal prion protein in biological samples. The procedure could be used to increase the sensitivity of tests for detecting these proteins, which are believed to cause transmissible spongiform encephalopathies (TSEs), such as Creutzfeldt-Jakob disease.